A randomised pilot study of symptom-driven versus routine follow-up in asymptomatic breast cancer patients receiving regular mammography
Not Applicable
Completed
- Conditions
- Breast cancerCancerBreast
- Registration Number
- ISRCTN43743674
- Lead Sponsor
- International Collaborative Cancer Group (ICGG) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Breast cancer stage I or II
2. No known metastases
3. No prior or concurrent treatment other than tamoxifen
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does symptom-driven follow-up compare to routine monitoring in detecting recurrence in ER-positive breast cancer patients?
What biomarkers predict recurrence risk in asymptomatic breast cancer patients undergoing regular mammography?
Are there adverse events associated with symptom-driven versus routine follow-up in breast cancer survivors?
How does the study's follow-up strategy impact patient quality of life in asymptomatic breast cancer cases?
What molecular mechanisms underlie recurrence in breast cancer patients with regular mammography screening?